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Abstract
Objectives: The actual future liver remnant (aFLR) is calculated as the ratio of remnant liver volume (RLV)
to total functional liver volume (TFLV). The standardized future liver remnant (sFLR) is calculated as the
ratio of RLV to standard liver volume (SLV). The aims of this study were to compare the aFLR with the sFLR
and to determine criteria for safe hepatectomy using computed tomography volumetry and indocyanine
green retention rate at 15 min (ICG R15).
Methods: Medical records and volumetric measurements were obtained retrospectively for 81 patients
who underwent right hemi-hepatectomy for malignant hepatic tumours from January 2010 to November
2013. The sFLR was compared with the aFLR, and a ratio of sFLR to ICG R15 as a predictor of
postoperative hepatic function was established.
Results: In patients without cirrhosis, the sFLR showed a stronger correlation with the total serum
bilirubin level than the aFLR (R2 = 0.499 versus R2 = 0.239). Post-hepatectomy liver failure developed only
in the group with an sFLR of <25%, regardless of ICG R15. In patients with cirrhosis, the aFLR and sFLR
had no correlation with postoperative total serum bilirubin. An sFLR : ICG R15 ratio of >1.9 showed 66.7%
sensitivity and 100% specificity.
Conclusions: Regardless of ICG R15, an sFLR of ≥25% in patients without cirrhosis, and an sFLR of
≥25% with an sFLR : ICG R15 ratio of >1.9 in patients with cirrhosis indicate acceptable levels of safety
in major hepatectomy.
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Introduction
Post-hepatectomy liver failure (PHLF) is one of the most serious
complications to arise after liver resection. Its occurrence is closely
related to the volume and functional capacity of the remnant liver.
Patients with a small future liver remnant (FLR) are at higher risk
for developing PHLF. There are two methods of calculating FLR.
Actual FLR (aFLR) is expressed as the ratio of remnant liver
volume (RLV) to total functional liver volume (TFLV). The TFLV
is calculated by subtracting the tumour volume (TV) from the
total liver volume (TLV). However, some patients have a smaller
TLV than expected. In these patients, a sufficient ratio would not
result in enough volume to meet metabolic demand. Therefore,
aFLR does not seem to be an appropriate metric for such patients.
The other method uses the standardized FLR (sFLR), which is
expressed as the ratio of RLV to standard liver volume (SLV). The
standardization of FLR is usually performed according to body
weight (BW) or body surface area (BSA).1–6 In the case of liver
transplantation, it is generally accepted that the ratio of graft
volume to SLV should be at least 30–40% to fulfil the hepatic
metabolic demand of the recipient.7–9 This concept is similar to
that of the sFLR. In a previous study by this group, the sFLR was
found to be more closely correlated with postoperative morbidity
and PHLF.10 An sFLR of about 20∼30% has been reported as
representing the limits of safety in hepatectomy by some
authors.1–3,5,6,11,12 However, these studies were performedmainly in
patients without cirrhosis and thus their data are not suitable for
application in patients with cirrhosis. In previous studies, the
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critical minimum FLR was estimated to be approximately 40% in
patients with cirrhosis.11,13 However, because patients with cirrho-
sis have impaired liver function, the risk associated with hepatec-
tomy cannot be determined accurately with volumetry alone.
Indocyanine green retention rate at 15 min (ICG R15) is the most
common preoperative test for evaluating hepatic functional
reserve.14,15 Some authors have proposed different surgical
approaches depending on ICG R15. Lee et al. reported a formula
for predicting a safe FLR ratio using ICG R15.16 Yamanaka et al.
proposed a predictive score for postoperative mortality calculated
from resection rate, ICG R15, and the patient’s age.17 In patients
with cirrhosis, these methods were more accurate, but were
complex to calculate. The aims of the present study were to evalu-
ate the significance of the sFLR (RLV : SLV) as a factor predictive
of liver function and liver failure after hepatic resection, in com-
parison with the aFLR (RLV : TFLV), and to determine accurate,
but easy-to-use and simple criteria for predicting PHLF using
computed tomography (CT) volumetry and ICG R15.
Materials and methods
From January 2010 to November 2013, 82 Korean patients under-
went right hemi-hepatectomy without biliary reconstruction for
malignant hepatic tumours at the Department of Surgery,
Chonnam National University Hwasun (CNUH) Hospital. The
medical records for the 82 patients were reviewed retrospectively.
One patient, who died of aspiration pneumonia following multi-
organ failure on postoperative day (PoD) 5, was excluded from the
study. Before the event, there were no abnormal clinical or labora-
tory findings. Thus, a total of 81 patients were selected. In order to
allow for a comparison of postoperative total serum bilirubin level
as an indicator of post-hepatectomy liver function, patients with
perihilar cholangiocarcinomas and gallbladder cancers were
excluded because all such patients submitted to right hemi-
hepatectomy had a biliary drainage catheter inserted at the time of
surgery. The biliary drainage catheter is the most important cause
of cholangitis and biliary infection can affect hepatic function. In
addition, routine lymphatic dissection in operations for hilar
cholangiocarcinomas and gallbladder cancers may affect the
amount of postoperative ascites.
Operative procedures
The liver was exposed via a right subcostal abdominal incision
with midline extension to the xiphoid process. Intraoperative
ultrasonography was used to confirm tumour resectability and
determine the appropriate line of resection. The liver was mobi-
lized completely from the posterior abdominal wall and rotated
anteromedially to expose the retrohepatic inferior vena cava
(IVC). Small tributaries draining into the IVC from the liver were
ligated individually and divided. The hepatocaval ligament was
separated and the right hepatic vein was looped. Hilar dissection
was undertaken to isolate and divide the right hepatic artery and
portal vein. The Pringle manoeuvre was not used in any patient.
Hepatic parenchymal transection was performed using an ultra-
sonic aspirator. After parenchymal dissection, the right hepatic
vein was divided and sutured.
Postoperative care
All patients received the same postoperative care delivered by the
same team of surgeons in the intensive care unit during the early
postoperative period. Parenteral nutritional support was pro-
vided for patients with liver cirrhosis. Early enteric nutrition was
encouraged once bowel activity returned. All intraoperative and
postoperative complications were recorded prospectively. Liver
function tests, including serum total bilirubin level and pro-
thrombin time (PT), were sampled routinely on PoD 1, 3, 5 and
7. Serum total bilirubin at PoD 1, 3, 5 and 7, and peak serum
total bilirubin were assessed to evaluate the relationship between
postoperative hepatic function and FLR. In addition, PT at PoD
1, 3, 5 and 7, and the lowest rate of PT were assessed. At PoD 7,
postoperative CT was carried out to recheck the anatomic resec-
tion and the similarity between the CT and virtual resection line
(Fig. 1). Post-hepatectomy liver failure was defined according to
three different methods. Firstly, clinical PHLF (PHLFclinic) was
defined as mortality with postoperative hepatic dysfunction or
the development of clinical symptoms such as bleeding ten-
dency, intractable ascites or hepatic encephalopathy.18 Secondly,
PHLF according to the ‘50–50 criterion’ (PHLF50–50) was defined
as both a PT of <50% and total serum bilirubin of >2.9 mg/dl
after PoD 5.19 Thirdly, PHLF according to total serum bilirubin
(PHLFpeakBil7) was defined as a peak total serum bilirubin (peakBil)
of >7 mg/dl.20 Postoperative mortality was defined as death
occurring during the postoperative hospital stay or within 90
days of surgery.20
Standard liver volume calculation
Standard liver volume was calculated using the formula reported
by Yu et al.21 as:
SLV ml BW kg height cm( ) = × ( ) × ( )21 585 0 732 0 225. .. .
Volumetric liver analysis using Dr Liver
All patients underwent contrast-enhanced CT as part of routine
preoperative assessment. Arterial, portal and venous phase series
of images from preoperative CT scans were used for CT
volumetry. Volumetric analysis using Dr Liver (Humanopia Co.
Ltd, Pohang, Gyungbuk, South Korea) was performed by two
surgeons (HJK and CYK). The liver was semi-automatically
extracted once multiple seed points had been selected on five or
six slices. The portal vein, hepatic vein, IVC and tumour were
extracted in the same manner. The TLV and TV were calculated
automatically with Dr Liver. The gallbladder and IVC were
excluded and the intrahepatic vascular and biliary structures were
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included in the liver volume calculation. The TFLV was calculated
using the formula:
TLV TV TFLV− = .
The transection line of the virtual liver resection followed the
middle hepatic vein (Fig. 1). The middle hepatic vein was
excluded from the virtual resection area.
Indocyanine green test
All patients underwent preoperative ICG R15 tests. Indocyanine
green tests consisted of an injection 0.5 mg/kg of ICG into a
peripheral vein and the drawing of a blood sample from another
site 15 min later. Results were expressed as the percentage of ICG
retained at 15 min after the injection.
Statistics
Continuous variables were expressed as the median (range) and
compared using the Mann–Whitney U-test. Discrete variables
were compared using the chi-squared test or Fisher’s exact test.
Correlations between continuous variables were assessed using
regression analysis. The resulting regression line was described as
a linear equation, and the correlation coefficients (R and R2) were
calculated. Cut-off values for the occurrence of PHLF were deter-
mined using receiver operating characteristic (ROC) curve analy-
sis. A P-value of <0.05 was considered to indicate statistical
significance. Statistical analysis was performed using pasw Statis-
tics for Windows Version 18.0 (SPSS, Inc., Chicago, IL, USA).
Results
Clinicopathologic characteristics and
operative outcomes
A total of 81 patients were evaluated in the present study. Their
median age was 59 years (range: 34–81 years). A total of 68
(84.0%) patients were male. Overall, 54 (66.7%) patients under-
went right hemi-hepatectomy for hepatocellular carcinoma, 16
(19.8%) for metastatic tumours, 10 (12.3%) for intrahepatic
cholangiocarcinoma, and one (1.3%) for carcinosarcoma. A total
of 38 (46.9%) patients had histologic evidence of liver cirrhosis.
All patients with a cirrhotic liver were of Child–Pugh class A
status. No patients had biliary obstruction, preoperative
hyperbilirubinaemia or preoperative PT prolongation. The clin-
icopathologic characteristics of patients are shown in Table 1. Of
the 81 patients who underwent right hemi-hepatectomy, clinical
PHLF occurred in eight (9.9%) patients, including four (4.9%)
who died. One patient with PHLFclinic underwent a liver transplan-
tation; four patients recovered with conservative treatment. Of the
four patients who died from liver failure in the postoperative
period, three had liver cirrhosis and one had chronic hepatitis B
without histologic evidence of liver cirrhosis. Of the 81 patients,
nine (11.1%) were classified in the PHLF50–50 group. All patients
with PHLFclinic were included in the PHLF50–50 group. One patient
Figure 1 (a–c) Virtual resection of liver using Dr Liver. The transection line of the virtual liver resection followed the middle hepatic vein. The
middle hepatic vein was excluded from the virtual resection area. (d) Follow-up computed tomography at postoperative day 7, used to
recheck the ‘anatomical’ right hemi-hepatectomy following the middle hepatic vein. The real resection line was similar to the virtual resection
line
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showed a serum total bilirubin level of 5.7 mg/dl and PT of 44% at
PoD 5, but displayed no symptoms of hepatic dysfunction such as
ascites, encephalopathy or bleeding tendency. The 50–50 criterion
showed sensitivity of 100% and specificity of 98.6% for the pre-
diction of clinical PHLF; however, sensitivity and specificity for
the prediction of mortality from PHLF declined to 44.4% and
93.5%, respectively. Four patients were classified in the PHLFpeakBil7
group, including three of the four patients who died and one
patient who underwent liver transplantation. The other patient
who died showed a peak serum bilirubin level of 6.8 mg/dl, which
was close to the 7 mg/dl level. Thus, all patients with grade C
PHLF (graded according to severity in line with the International
Study Group of Liver Surgery18) were classified as within the
PHLFpeakBil7 group. The criterion defined as a peak bilirubin level
of >7 mg/dl (except for the patient with peak bilirubin of 6.8 mg/
dl) showed sensitivity of 75.0% and specificity of 98.7% for the
prediction of mortality, but showed lower sensitivity (50.0%) and
specificity (94.8%) for the prediction of clinical PHLF.
Correlations between aFLR, sFLR, sFLR : ICG R15
and postoperative liver function
In patients without cirrhosis, aFLR, sFLR and the sFLR : ICG R15
ratio showed significant correlations with postoperative total
serum bilirubin and PT at every postoperative measurement and
with peak values. Among postoperative total serum bilirubin
measurements, the level at PoD 5 showed a stronger correlation
with sFLR (correlation between bilirubin level and 1/sFLR: P <
0.001, R = 0.763, R2 = 0.582) than with aFLR (correlation between
bilirubin level and 1/aFLR: P < 0.001, R = 0.309, R2 = 0.556) and
the sFLR : ICG R15 ratio (correlation between bilirubin level and
sFLR : ICG R15: P < 0.001, R = 0.574, R2 = 0.329) (Fig. 2). In
patients with cirrhosis, aFLR, sFLR and sFLR : ICG R15 showed
no significant correlation with postoperative serum total bilirubin
and PT at any PoD in regression analysis (Fig. 2).
Determination of cut-off value of sFLR : ICG R15 in
patients with cirrhosis
When the ratio of sFLR to ICG R15 was assessed with ROC analy-
sis for the occurrence of PHLF in patients with cirrhosis, the same
cut-off value, 1.87, was obtained (area under the curve [AUC]:
0.755). An additional assessment was performed to obtain the
cut-off value of the sFLR : ICG R15 ratio in patients with cirrho-
sis. Lee et al. have reported a formula for predicting the safe limit
of hepatectomy,16 expressed as:
safe FLR limit Lee s FLR ICG R’ . . .( ) = × +1 98 15 0 3672
In this equation, FLR is expressed as the sFLR and SLV is cal-
culated from the equation:
SLV ml BSA m( ) = × ( )+706 2 2 42. . .16,22
Given the differences in the methods of calculating SLV, a ratio
of sFLR to Lee’s FLR was calculated to compare sFLR and Lee’s
Table 1 Clinicopathologic and preoperative laboratory characteristics in 81 patients submitted to hemi-hepatectomy
All patients (n = 81) Without cirrhosis (n = 43) With cirrhosis (n = 38) P-value
Age, years, median (range) 59 (34–81) 61 (42–81) 58 (34–73) NS
Gender, male/female, n 68/13 35/8 33/5 NS
Type of tumour, n (%)
Hepatocellular carcinoma 54 (66.7%) 18 (41.9%) 36 (94.7%) <0.001
Metastases 16 (19.8%) 16 (37.2%) 0
IHCCA 10 (12.3%) 8 (18.6%) 2 (5.3%)
Others 1 (1.2%) 1 (2.3%) 0
Preoperative liver function, median (range)
Serum total bilirubin, mg/dl 0.60 (0.20–1.20) 0.50 (0.30–1.20) 0.60 (0.20–1.10) NS
Prothrombin time, % 101.00 (68.00–134.00) 105.00 (68.00–126.00) 95.50 (75.00–134.00) NS
ICG R15, % 11.40 (0.10–22.40) 10.30 (0.10–22.40) 12.20 (0.40–22.20) NS
Volumetric assessment, median (range)
TFLV, ml 1214 (773–2297) 1217 (773–1745) 1172 (793–2297) NS
SLV, ml 1407 (1032–2338) 1360 (1163–1730) 1434 (1032–2338) NS
TFLV : SLV, % 87.55 (47.82–116.75) 88.91 (47.82–116.75) 84.09 (59.72–113.53) NS
RLV, ml 514.00 (276–1040) 514.00 (276–1035) 514.50 (316–1040) NS
aFLR, % 41.58 (28.15–68.26) 41.34 (28.15–60.39) 43.05 (30.07–68.26) NS
sFLR, % 37.02 (18.00–70.50) 37.02 (18.00–70.50) 37.25 (25.20–58.58) NS
IHCCA, intrahepatic cholangiocarcinoma; ICG R15, indocyanine green retention rate at 15 min; TFLV, total functional liver volume; SLV, standard liver
volume; aFLR, actual future liver remnant; sFLR, standardized future liver remnant; NS, not significant.
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FLR. Receiver operating curve analysis was used to identify a
cut-off value of the sFLR : Lee’s FLR ratio in predicting PHLF; the
identified cut-off value was 0.9595. Accordingly, this resulted in
the formula:
safe limit of sFLR Lee s FLR
ICG R
= ×
= × +
0 9595
1 8998 15 0 3523
.
. . .
’
Because 0.3523% of sFLR is a very small value, the equation can
be simplified and expressed as:
safe limit of sFLR ICG R≈ ×1 9 15. .
Two methods to determine the cut-off value of sFLR : ICG R15
showed similar results. Therefore, a safe limit for hepatectomy in
patients with cirrhosis can be expressed as the following simple
equation:
sFLR
ICGR15
1 9> .
Comparison of aFLR, sFLR and sFLR : ICGR15 as
predictor of PHLF
In patients without cirrhosis, aFLR, sFLR and sFLR : ICG R15
were significantly lower in the PHLF group than in the non-PHLF
group (P = 0.021, P < 0.001 and P = 0.001, respectively). However,
in patients with cirrhosis, there were no significant differences in
aFLR and sFLR between the PHLF and non-PHLF groups. Only
the sFLR : ICG R15 ratio differed significantly between the PHLF
and non-PHLF groups (Table 2). In patients without cirrhosis, the
cut-off values for aFLR, sFLR and sFLR : ICG R15 determined
using ROC analysis were 33%, 25% and 1.7, respectively (AUC:
0.908, 1.000 and 0.992, respectively). Among these, sFLR was the
most useful predictor of PHLF in patients without cirrhosis. In
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Figure 2 Correlations between actual future liver remnant (aFLR), standardized future liver remnant (sFLR), the sFLR : indocyanine green
retention at 15 min (ICG R15) ratio and postoperative serum total bilirubin on postoperative day (PoD) 5. Open circles indicate patients
without post-hepatectomy liver failure (PHLF); closed triangles indicate patients with PHLF. (a–c) Significant correlations emerged between
aFLR, sFLR, sFLR : ICG R15 and serum total bilirubin in patients without cirrhosis: sFLR showed the strongest correlation with postoperative
serum total bilirubin compared with aFLR and sFLR : ICG R15. (d–f) However, aFLR, sFLR and sFLR : ICG R15 did not show significant
correlations with serum total bilirubin at PoD 5 in patients with cirrhosis
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patients without cirrhosis, PHLF developed only in patients with
an sFLR of <25%, among whom an sFLR of <25% demonstrated
100% sensitivity and 100% specificity in predicting PHLF. In
patients with cirrhosis, the cut-off values of aFLR, sFLR and
sFLR : ICG R15 determined using ROC analysis were 41%, 30%
and 1.9, respectively (AUC: 0.547, 0.641 and 0.755, respectively).
An sFLR : ICG R15 ratio of <1.9 was the most useful predictor of
PHLF in patients with cirrhosis, demonstrating 66.7% sensitivity
and 100% specificity. Predictive values of the aFLR, sFLR and
sFLR : ICG R15 ratio are displayed in Table 3. Because patients
with cirrhosis have impaired hepatic function compared with
patients without cirrhosis, in patients with cirrhosis the sFLR
should exceed 25%. Therefore, a simple set of criteria for safe
hepatic resection, named the CNUH criteria, are proposed: (i) in
patients without cirrhosis, if the sFLR is >25%, hepatectomy can
be performed safely, and (ii) in patients with cirrhosis, if the sFLR
is >25% and the sFLR : ICG R15 ratio is >1.9, hepatectomy can be
performed safely.
Discussion
Remnant liver volume after resection is a critical factor for pre-
dicting postoperative outcomes. Generally, the accepted limit for
the ratio of the FLR for safe resection in normal liver ranges from
Table 2 Comparison of actual future liver remnant (FLR), standardized FLR, indocyanine green retention rate at 15 min (ICG R15), and the
standardized FLR : ICG R15 ratio between patients with and without post-hepatectomy liver failure (PHLF)
PHLF50–50 P-value
Yes No
Without cirrhosis n = 3 n = 40
aFLR, %, median (range) 32.94 (28.84–37.65) 41.55 (28.15–60.39) 0.013
sFLR, %, median (range) 21.12 (18.00–22.73) 38.54 (25.74–70.50) <0.001
ICG R15, %, median (range) 16.10 (14.40–16.60) 9.95 (0.10–22.40) 0.074
sFLR : ICG R15 median (range) 1.27 (1.11–1.57) 3.59 (1.43–460.6) <0.001
With cirrhosis n = 6 n = 32
aFLR, %, median (range) 40.50 (32.63–52.19) 43.77 (30.07–68.26) 0.740
sFLR, %, median (range) 29.48 (26.13–49.54) 38.43 (25.20–58.58) 0.297
ICG R15, %, median (range) 15.65 (4.80–22.20) 11.80 (0.40–19.90) 0.199
sFLR : ICG R15 median (range) 1.80 (1.17–10.32) 3.29 (1.90–128.80) 0.050
Statistical significance was tested using the Mann–Whitney U-test.
aFLR, actual future liver remnant; sFLR, standardized future liver remnant.
Table 3 Actual future liver remnant (FLR), standardized FLR, and the ratio of standardized FLR to indocyanine green retention rate at 15 min
(ICG R15) as predictors of post-hepatectomy liver failure (PHLF) after major hepatectomy
PHLF50–50 AUC Sensitivity Specificity PPV NPV P-value
Yes No
Without cirrhosis
aFLR <33% 2 3 0.908 66.7% 92.5% 40.0% 97.4% 0.032
≥33% 1 37
sFLR <25% 3 0 1.000 100% 100% 100% 100% <0.001
≥25% 0 40
sFLR : ICG R15 <1.7 3 1 0.992 100% 97.5% 75.0% 100% <0.001
≥1.7 0 39
With cirrhosis
aFLR <41% 4 12 0.547 66.7% 62.5% 25.0% 90.9% 0.190
≥41% 2 20
sFLR <30% 4 6 0.641 66.7% 81.3% 40.0% 92.9% 0.031
≥30% 2 26
sFLR : ICG R15 <1.9 4 0 0.755 66.7% 100% 100% 94.1% <0.001
≥1.9 2 32
AUC, area under the curve; PPV, positive predictive value; NPV, negative predictive value; aFLR, actual future liver remnant; sFLR, standardized future
liver remnant.
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20% to 30%, according to different authors.3,6,11,23,24 Several
authors have proposed that direct CT measurement of the TFLV
may be inaccurate for the following reasons: (i) measurement of
TFLV is subject to cumulative error associated with the presence
of multiple tumours or intrahepatic bile duct dilatation;3,25,26 (ii)
tumours compressing or invading the portal vein or bile ducts
induce atrophy of the involved liver and in such cases measured
TFLV may not reflect accurate liver function, and (iii) measured
TFLV does not provide a fixed estimation of TFLV before and after
portal vein embolization (PVE) because in cases of atrophy
without contralateral hypertrophy from PVE, the use of a smaller
post-PVE TFLV as a denominator for calculating the FLR may
falsely indicate a change in volume (hypertrophy).3 To overcome
the errors associated with traditional liver volumetry, Urata et al.
introduced the concept of SLV based on the observation that in
adults without chronic liver disease, liver volume has a linear
correlation with body size and weight.22 Vauthey et al. described a
minimum safe sFLR of 25% in patients without cirrhosis under-
going extended right hepatectomy and described the occurrence
of major postoperative complications in three of five patients with
sFLR volumes of ≤25%, compared with no major complications
in the remaining 10 of the resected group with sFLR volumes of
>25% (P = 0.002).6 Abdalla et al. reported the occurrence of post-
operative complications in 50% of patients submitted to extended
right hepatectomy with sFLR volumes of ≤20% but in only 13% of
patients with sFLR volumes of >20%.2 Kishi et al. identified sig-
nificant increases in the frequencies of liver insufficiency and
death from liver failure in patients with sFLR volumes of ≤20%
(34% and 11%, respectively), compared with patients with sFLR
volumes of 20∼30% (10% and 3%, respectively; P < 0.001 and P =
0.038).3 More recently, Narita et al. reported that aFLR and sFLR
were independent predictors of the occurrence of postoperative
liver failure.5 However, no direct comparison of the two ratios was
performed. All of these studies were performed in patients
without cirrhosis. In the present study, sFLR showed a stronger
correlation with postoperative total serum bilirubin and a more
accurate predictive value compared with sFLR and sFLR : ICG
R15 values in patients without cirrhosis (Fig. 2, Table 2). Further,
an sFLR volume of >25% was found to be an acceptable indicator
for safe hepatectomy in patients without cirrhosis. This is consist-
ent with values reported in previous studies.
Truant et al. reported that an FLRmeasurement standardized to
BW was more specific than an aFLR in predicting the postopera-
tive course after extended hepatectomy.4 More recently, a com-
parison of FLR measurements standardized to BW and BSA
showed the two methods to be highly correlated and to yield
similar results in predicting postoperative hepatic dysfunction.1
The authors reported that in patients without cirrhosis, an
FLR : BW of ≤0.4 and an FLR : SLV ratio of ≤20% provide equiva-
lent thresholds for safe hepatic resection.1 Although the method of
standardizing the FLR differed from that used in the present study,
the finding that sFLR is more accurate than aFLR is similar to the
present results.
The determination of the safe limits for liver resection in
patients with cirrhosis is more complex because the degree of
hepatic dysfunction that is not describable by Child–Pugh class is
widely variable. Therefore, some authors have proposed a differ-
ent surgical approach depending on the ICG R15. Lee et al. dem-
onstrated the relationship between the ratio of RLV and
preoperative ICG R15 in patients with postoperative liver dys-
function.16 The authors calculated the FLR ratio with the SLV. The
SLV was calculated using the formula:
SLV ml BSA m( ) = × ( )+706 2 2 42. . .22
The authors expressed the limit of safe hepatic resection using
the formula:
ratio of RLV RR ICG R( ) = × +1 98 15 0 3672. . .
The safe limit for hepatic resection for all patients enrolled in
the present study was calculated using the equation and methods
described by Lee et al.16 When the criteria selected in the present
study and Lee et al.’s formula16 were compared as predictors of
PHLF, the latter showed good predictive value; however, the speci-
ficity of the criteria outlined in the present study was slightly
higher in patients without cirrhosis, and their sensitivity in
patients with cirrhosis was slightly higher (Table 4). The most
remarkable difference between the present criteria and Lee et al.’s
formula16 refers to the need to secure the minimal volume
required to meet the patient’s metabolic demand, regardless of the
ICG R15. The minimal volume identified in the present study was
25% of sFLR.
In 1984,Yamanaka et al. reported a formula for predicting mor-
tality.27 Later, in 1994, the same authors reported further outcomes
of using this method.17 Yamanaka et al. used the parenchymal
hepatic resection rate (PHRR) calculated using CT. This repre-
sented the concept of ‘actual FLR’. In this system, patients were
classified within the following categories of safe, borderline and
risky according to prediction score. The authors reported that all
of the three patients with metastatic cancers in the risky zone died,
but none of the six patients in the borderline zone and the 49
patients in the safe zone with metastatic cancers died. The predic-
tion scores for the 81 patients in the present series were calculated
according to the formula of Yamanaka et al.27 The PHRR was
calculated with the formula:
PHRR aFLR% .( ) = −100
When this prediction scoring system was applied in the present
patient series, it showed a favourable negative predictive value, but
its positive predictive value was not satisfactory, especially in
patients with cirrhosis (Table 4). There were some remarkable
differences between this method and the criteria developed in the
present study. Firstly, the method described by Yamanaka et al.
uses aFLR expressed as the PHRR.27,28 Secondly, the authors
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assessed the scoring system for mortality, not for PHLF, and thus
deaths from other causes were included. Thirdly, age was used as a
predictor. However, the present authors were unable to find any
significant correlation between age and PHLF. Previously,
Nanashima et al. showed the incidence of PHLF to be unaffected
by age despite the fact that systemic complications increase in
elderly patients.29
In the present study, sFLR was more suitable for the prediction
of PHLF in patients without cirrhosis than the sFLR : ICG R15
ratio; however, the sFLR : ICG R15 ratio was more suitable in
patients with cirrhosis than the sFLR. This result is generally
attributed to the difference in regenerative function between
patients with and without cirrhosis. Tiberio et al. reported that
cirrhotic livers demonstrate lower levels of hepatocyte growth
factor and other transcription factors, leading to a reduction in
DNA synthesis and lower volumes of regenerated liver.30 More-
over, Corpechot et al. reported that cirrhotic livers show an
increased risk for ischaemia–reperfusion injury and fibrosis,
leading to regional ischaemia and contributing to impaired
growth and regeneration.31 This claim needs to be investigated
further.
The present study is subject to some notable limitations. Firstly,
because the incidence of PHLF was very low, it is difficult to
confirm whether an sFLR volume of 25% and an sFLR : ICG R15
ratio of 1.9 are truly acceptable or not. In addition, the small size
of the retrospective cohort highlights the need for more highly
powered prospective studies. Nonetheless, the present study has
delivered a set of ‘simple’ criteria for determining the safety of
hepatic resection in patients with and without cirrhosis.
Conclusions
In conclusion, the sFLR volume was more relevant than that of the
aFLR in predicting postoperative hepatic function and PHLF after
right hemi-hepatectomy. The present simple criteria, expressed as
an sFLR volume of >25%, regardless of ICG R15 level, in patients
without cirrhosis, and an sFLR of >25% and an sFLR : ICG R15
ratio of >1.9 in patients with cirrhosis, are acceptable for predict-
ing the safety of hepatic resection. These results require to be
confirmed in a larger-scale, multicentre and prospective study.
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